NanomedicineZPH Technology has the potential to be integrated into the combination therapies, offering numerous cutting-edge, transformative, sophisticated, visionary, and trailblazing outcomes.
"In medias res" (Latin for "in the midst of things") or "value proposition-first" strategies:
What's Happening in #BreastCancer Therapies in the #GlobalMarket?
1. Hormone Receptor-Positive (HR+) Breast Cancer
Combination Therapy:
Endocrine Therapy (like tamoxifen or aromatase inhibitors) + CDK4/6 Inhibitors (like palbociclib, ribociclib, or abemaciclib).
Endocrine Therapy (such as exemestane) + mTOR Inhibitors (like everolimus).
2. HER2-Positive Breast Cancer
Combination Therapy:
HER2-Targeted Therapy + Chemotherapy:
Example: Trastuzumab + Pertuzumab + Docetaxel (known as the "THP" regimen).
Trastuzumab + Paclitaxel (Taxol) or other taxane-based regimens
Trastuzumab biosimilars (e.g., Kanjinti and Herzuma) are also commonly used as alternatives to Herceptin due to lower cost and similar efficacy.
HER2-Targeted Therapy + T-DM1:
Example: T-DM1 following trastuzumab + chemotherapy combination.
HER2-Targeted Therapy + CDK4/6 Inhibitors: Some ongoing studies suggest adding CDK4/6 inhibitors (like palbociclib) to HER2-targeted therapy may improve outcomes for HER2+/HR+ cancers.
3. Triple-Negative Breast Cancer (TNBC)
Combination Therapy:
Chemotherapy + Immunotherapy:
Example: atezolizumab (Tecentriq) + nab-paclitaxel (Abraxane).
Chemotherapy Combinations:
Example: Doxorubicin + Cyclophosphamide (AC) followed by Paclitaxel.
Carboplatin + Taxane-based Chemotherapy
PARP Inhibitors + Chemotherapy:
Example: Olaparib (Lynparza) + Carboplatin or Talazoparib (Talzenna)
4. Locally Advanced or Early-Stage Breast Cancer
Common Combinations:
Chemotherapy + long-term Endocrine Therapy:
Example: Doxorubicin + Cyclophosphamide + Endocrine Therapy.
Chemotherapy + HER2-Targeted Therapy:
Example: Trastuzumab + Chemotherapy (such as paclitaxel).
5. Neoadjuvant (pre-surgical) and Adjuvant Therapy (post-surgical)
Combination Examples:
Neoadjuvant Chemotherapy + HER2-Targeted Therapy:
Example: Trastuzumab + Pertuzumab + Docetaxel (THP regimen, used neoadjuvantly)
Adjuvant Endocrine Therapy + CDK4/6 Inhibitors:
Example: Abemaciclib + Endocrine Therapy.
Nanomedicine & Nanodrugs ZPH GmbH | Deutschland
